# Selegiline for Smoking Cessation - 1

> **NCT00439413** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 246 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Selegiline Transdermal Patch
- **DRUG:** Placebo
- **BEHAVIORAL:** Smoking Cessation Counseling

## Key facts

- **NCT ID:** NCT00439413
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-08
- **Final completion:** 2009-01
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2017-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439413, "Selegiline for Smoking Cessation - 1". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00439413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*